Harvest Declares Big Pharma Split Corp. November 2025 Distribution

Harvest Portfolios Group Inc. has announced a monthly cash distribution for Big Pharma Split Corp. (PRM: TSX) amounting to $0.1031 per Class A share for the month ending November 30, 2025. This distribution is scheduled to be paid on December 5, 2025, to all Class A shareholders who are on record as of the close of business on November 28, 2025.

Founded in 2009, Harvest is an independent Canadian investment fund manager that oversees $9.6 billion in assets for Canadian investors. The company is focused on strategies that allow investors to build and preserve wealth through long-term ownership of high-quality businesses. This fundamental approach forms the bedrock of their investment strategy across a variety of Exchange-Traded Funds (ETFs).

Harvest offers a diverse range of ETFs that center around covered call strategies, tailored to encompass various asset classes, including equity, fixed income, and specialty areas. Their product offerings also include multi-asset solutions and unique digital asset opportunities, allowing investors to find tailored investment options that fit their needs.

For more information, interested parties can visit Harvest's official website or contact them directly via email. There is also a dedicated media contact for inquiries. Additionally, Harvest engages with its audience through social media platforms, including LinkedIn, Twitter, Facebook, and YouTube.

Investors should be aware that purchasing or selling shares of the investment fund usually incurs brokerage fees. It's essential for investors to read the fund’s disclosure documents for comprehensive details on potential risks, ongoing fees, and the investment fund's overall performance.

For further details on this distribution and other investment opportunities, visit Harvest's site or reach out via the provided contact information.

Harvest Portfolios Group Inc.'s recent announcement regarding the monthly cash distribution for Big Pharma Split Corp. offers valuable insights for investors. The declared distribution of $0.1031 per class A share (PRM:TSX) for November 2025, payable on December 5, is indicative of the fund's commitment to providing regular income to its shareholders. With the record date set for November 28, 2025, investors seeking steady returns may find this an opportune time to evaluate their positions.

With Harvest managing approximately $9.6 billion in assets, their investment philosophy centers around long-term wealth creation through high-quality businesses. Here, a focus on covered call strategies suggests that they seek to capitalize on stable market conditions while providing downside protection. For investors, this indicates that Big Pharma Split Corp. may be positioned to weather market volatility, especially in an unpredictable economic environment.

Investors should closely monitor the broader pharmaceutical sector as well, given its resilience during economic downturns and ongoing demand for healthcare solutions. The emphasis on sustainable income from a reputable fund manager like Harvest presents an appealing option for strategic asset allocation, particularly for those prioritizing income over growth.

However, potential investors should remain cautious of inherent risks associated with investment funds, including brokerage fees and market fluctuations. Continuous evaluation of the fund's performance relative to its peers and the broader market trends will be prudent.

In summary, Harvest's declared distribution is a positive signal for current and prospective shareholders of Big Pharma Split Corp. As such, it may be wise to leverage this opportunity to either enter or bolster positions within a defensively structured portfolio, especially amid the current economic landscape.